We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current SNPHY market cap is 4.29B. The company's latest EPS is JPY 73.3606 and P/E is 0.15.
Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Total Revenue | 241.95B | 265.61B | 266.81B | 282.56B | 302.65B |
Operating Income | 33.55B | 12.66B | 33.87B | -4.9B | 30.98B |
Net Income | 21.71B | 6.65B | 27.19B | -14.98B | 26.7B |
Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Total Assets | 408.77B | 402.35B | 459.98B | 421.18B | 435.7B |
Total Liabilities | 106.21B | 95.3B | 123.13B | 127.88B | 130.33B |
Total Equity | 302.56B | 307.05B | 336.84B | 293.3B | 305.37B |
Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Operating | 39.95B | 38.81B | 46.04B | 37.15B | 72.65B |
Investing | -5.17B | -53.36B | -35.17B | -26.78B | -6.15B |
Financing | -12.73B | -16.69B | 5.56B | -37.22B | -34.03B |
Market Cap | 4.29B |
Price to Earnings Ratio | 0.15 |
Price to Sales Ratio | 0.01 |
Price to Cash Ratio | 0.04 |
Price to Book Ratio | 0.01 |
Dividend Yield | 1.85% |
Shares Outstanding | 364M |
Average Volume (1 week) | 2.41k |
Average Volume (1 Month) | 6.76k |
52 Week Change | 25.70% |
52 Week High | 13.00 |
52 Week Low | 8.95 |
Spread (Intraday) | 1.18 (9.22%) |
Company Name | Santen Pharmaceutical Company (PK) |
Address |
4-20 ofuka town higashiosaka, osaka 533-8651 |
Website | https://www.santen.co.jp |
Industry | pharmaceutical diversified (H2) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions